People: Par Pharmaceutical Companies, Inc. (PRX)

Mr. Lawrence A. Kenyon became Executive Vice President - Finance of Par Pharmaceutical Companies, Inc., on December 15, 2008 and assumed the role of Executive Vice President and Chief Financial Officer as of March 9, 2009. Prior to joining Par, Mr. Kenyon served as Chief Operating Officer (since November 2007) and as Executive Vice President, Chief Financial Officer and Corporate Secretary (since January 2007) of Alfacell Corporation. Mr. Kenyon also served as a member of the board of directors of Alfacell. Through February 17, 2009, Mr. Kenyon also acted as President, Chief Financial Officer and Corporate Secretary of Alfacell. Prior to joining Alfacell, Mr. Kenyon served as Executive Vice President, Chief Financial Officer and Corporate Secretary at NeoPharm, Inc., a publicly traded biopharmaceutical company, from 2000 until 2006.